Latent inhibition in smokers vs. nonsmokers: Interaction with number or intensity of preexposures?

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 2, 1999, Pages 353-359

  Della Casa, Vera ^a   Höfer, Ilse ^a   Feldon, Joram ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Attention; Human; Latent inhibition; Nicotine; Smoking

Indexed keywords

NICOTINE;

ADULT; ARTICLE; ATTENTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; LATENT INHIBITION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING;

ACOUSTIC STIMULATION; ADULT; ATTENTION; FEMALE; HUMANS; INTERPERSONAL RELATIONS; LEARNING; MALE; MIDDLE AGED; NEURAL INHIBITION; NICOTINE; RETROSPECTIVE STUDIES; SMOKING;

EID: 0344267649     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00172-5     Document Type: Article

References (34)

1. Allan L.M., Williams J.H., Wellman N.A., Tonin J., Taylor E., Feldon J., Rawlins J.N.P. Effects of tobacco smoking, schizotypy and number of pre-exposures on latent inhibition in healthy subjects. Person. Individ. Diff. 19:1995;893-902.
2. Baruch I., Hemsley D.R., Gray J.A. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J. Nerv. Ment. Dis. 176:1988;598-606.
3. Baruch I., Hemsley D.R., Gray J.A. Latent inhibition and "psychotic proneness" in normal subjects. Person. Individ. Diff. 9:1988;777-783.
4. Bentall R.P., Claridge G.S., Slade P.D. The multidimensional nature of schizotypal traits. A factor analytic study with normal subjects Br. J. Clin. Psychol. 28:1989;363-375.
5. Crowell C.R., Anderson D.C. Variations in intensity, interstimulus interval and interval between CS exposure and conditioning with rats. J. Comp. Physiol. Psychol. 79:1972;291-298.
6. De la Casa G., Lubow R.E. Latent inhibition in conditioned taste aversion. The roles of stimulus frequency and duration and the amount of fluid ingested during preexposure Neurobiol. Learn. Mem. 64:1995;125-132.
7. De la Casa L.G., Ruiz G., Lubow R.E. Amphetamine-produced attenuation of latent inhibition is modulated by stimulus preexposure duration. Implications for schizophrenia Biol. Psychiatry. 33:1993;707-711.
8. De la Casa L.G., Ruiz G., Lubow R.E. Latent inhibition and recall/recognition of irrelevant stimuli as a function of pre-exposure duration in high and low psychotic-prone normal subjects. Br. J. Psychol. 84:1993;119-132.
9. Della Casa, V.; Höfer, I.; Weiner, I.; Feldon, J.: Effects of smoking status and schizotypy on latent inhibition. J. Psychopharmacol. (in press).
10. Feldon J., Weiner I. An animal model of attention deficit. Boulton A., Baker G., Martin-Iverson M. Neuromethods, vol. 18. Animal models in psychiatry:1991;313-361 Humana Press, Clifton, NJ.
11. Ginton A., Urca G., Lubow R.E. The effects of preexposure to a nonattended stimulus on subsequent learning. Latent inhibition in adults Bull. Psychonom. Soc. 5:1975;5-8.
12. Gray J.A., Mitchell S.N., Joseph M.H., Grigoryan G.A., Dawe S., Hodges H. Neurochemical mechanisms mediating the behavioral and cognitive effects of nicotine. Drug Dev. Res. 31:1994;3-17.
13. Gray N.S., Pickering A.D., Hemsley D.R., Dawling S., Gray J.A. Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man. Psychopharmacology (Berlin). 107:1992;425-430.
14. Imperato A., Mulas A., Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 132:1986;337-338.
15. Joseph M.H., Peters S.L., Gray J.A. Nicotine blocks latent inhibition in rats. Evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure Psychopharmacology (Berlin). 110:1993;187-192.
16. Kalbfleisch J.D., Prentice R.L. The statistical analysis of failure time data. 1980;John Wiley & Sons, New York.
17. Lee E.T. Statistical methods for survival data analysis. 1992;John Wiley & Sons, New York.
18. Lubow R.E. Latent inhibition. Psychol. Bull. 79:1973;398-407.
19. Lubow R.E. Latent inhibition and conditioned attention theory. 1989;Cambridge University Press, New York.
20. Lubow R.E., Gewirtz J.C. Latent inhibition in humans. Data, theory, and implications for schizophrenia Psychol. Bull. 117:1995;87-103.
21. Lubow R.E., Moore A.U. Latent inhibition. The effect of nonreinforced pre-exposure to the conditional stimulus J. Comp. Physiol. Psychol. 52:1959;415-419.
22. Moran P.M., Fischer T.R., Hitchcock J.M., Moser P.C. Effects of clozapine on latent inhibition in the rat. Behav. Pharmacol. 7:1996;42-48.
23. Moser P.C., Moran P.M. Effects of the 5HT-2 antagonist MDL 100, 907 on latent inhibition in the rat. Behav. Pharmacol. 5:1994;120-121.
24. Orne M.T. On the social psychology of the psychological experiment. With particular reference to demand characteristics and their implications Am. Psychol. 17:1962;776-783.
25. Rochford J., Sen A.P., Quirion R. Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat. J. Pharmacol. Exp. Ther. 277:1996;1267-1275.
26. Ruob C., Elsner J., Weiner I., Feldon J. Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus. Behav. Brain Res. 88:1997;35-41.
27. Schnur P., Lubow R.E. Latent inhibition. The effect of ITI and CS intensity during preexposure Learn. Mot. 7:1976;540-550.
28. Solomon P.R., Crider A., Winkelman J.W., Turi A., Kramer R.M., Kaplan L.J. Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity. Relationship to schizophrenic attention disorder Biol. Psychiatry. 16:1981;519-538.
29. Thornton J.C., Dawe S., Lee C., Capstick C., Corr P.J., Cotter P., Frangou S., Gray N.S., Russell M.A.H., Gray J.A. Effects of nicotine and amphetamine on latent inhibition in human subjects. Psychopharmacology (Berlin). 127:1996;164-173.
30. Warburton E.C., Mitchell S.N., Joseph M.H. Calcium dependence of sensitised dopamine release in rat nucleus accumbens following amphetamine challenge. Implications for the disruption of latent inhibition Behav. Pharmacol. 7:1996;119-129.
31. Weiner I., Lubow R.E., Feldon J. Chronic amphetamine and latent inhibition. Behav. Brain Res. 2:1981;285-286.
32. Weiner I., Lubow R.E., Feldon J. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology (Berlin). 83:1984;194-199.
33. Williams J.H., Wellman N.A., Geaney D.P., Cowen P.J., Feldon J., Rawlins J.N.P. Antipsychotic drug effects in a model of schizophrenic attentional disorder. A randomized controlled trial of the effects of haloperidol on latent inhibition in healthy people Biol. Psychiatry. 40:1996;1135-1143.
34. Williams J.H., Wellman N.A., Geaney D.P., Feldon J., Cowen P.J., Rawlins J.N.P. Haloperidol enhances latent inhibiton in visual tasks in healthy people. Psychopharmacology (Berlin). 133:1997;262-268.